一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

TocilizuMab

TocilizuMab Struktur
375823-41-9
CAS-Nr.
375823-41-9
Englisch Name:
TocilizuMab
Synonyma:
Actemra;Atlizumab;2180;R 1569;RoActemra;Actemra 200;TocilizuMab;Tocilizumab-Actemra;Tocilizumab 20mg/ml;Tocilizumab,Atlizumab
CBNumber:
CB32735437
Summenformel:
C14H12O3
Molgewicht:
0
MOL-Datei:
Mol file

TocilizuMab Eigenschaften

storage temp. 
Store at -80°C
L?slichkeit
Soluble in DMSO
Aggregatzustand
Liquid
Farbe
Colorless to light yellow

Sicherheit

TocilizuMab Chemische Eigenschaften,Einsatz,Produktion Methoden

History

TocilizuMab (trade name: Actemra) is an antirheumatoid arthritis drug developed by Genentech, Inc.  It was first approved by the FDA on January 8, 2010, for the treatment of moderate to severe active rheumatoid arthritis.  On June 24, 2021, Actemra received Emergency Use Authorization from the FDA for the treatment of hospitalized adults and children with COVID-19, but not for outpatients with COVID-19.  At this time, it had not yet received formal approval.  By December 21, 2022, the FDA approved Actemra for the treatment of hospitalized adults with COVID-19.

TocilizuMab Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


TocilizuMab Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 121)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hebei Chuanghai Biotechnology Co., Ltd
+8615350571055
Sibel@chuanghaibio.com China 8738 58
Career Henan Chemica Co
+86-0371-86658258 +8613203830695
laboratory@coreychem.com China 30224 58
Shanghai Minbiotech Co., Ltd.
+8617315815539
sales@minbiotech.com CHINA 129 58
AFINE CHEMICALS LIMITED
+86-571-85134551
info@afinechem.com China 15080 58
Wuhan Fortuna Chemical Co., Ltd
+86-27-59207850
info@fortunachem.com China 5994 58
Hefei Hirisun Pharmatech Co., Ltd
+8615056975894
shawn@hirisunpharm.com CHINA 9911 58
Guangzhou TongYi biochemistry technology Co.,LTD
+8613073028829
tongyibiochem@163.com China 2995 58
Hebei Fengjia New Material Co., Ltd
+86-0311-87836622 +86-18712993135
sales01@tairunfaz.com China 8051 58
TargetMol Chemicals Inc.
+1-781-999-5354;
support@targetmol.com United States 39037 58
Dingwang Technology (Wuhan) Co., Ltd.
+undefined-27-2786652399 +undefined13627115097
market02@senwayer.com China 887 58

  • TocilizuMab
  • Actemra 200
  • R 1569
  • RoActemra
  • Tocilizumab,Atlizumab
  • anti-IL-6R Tocilizumab
  • Tocilizumab (anti-IL-6R)
  • Tocilizumab-Actemra
  • Actemra
  • Atlizumab
  • Research Grade Tocilizumab(DHC36902)
  • COVID-19,IL-6R,Anti-Human IL6R, Humanized Antibody,rheumatoid,respiratory failure,antibody,Interleukin Related,coronavirus disease,Tocilizumab,arthritis,inhibit,dyspnoea,Neutralizing,Inhibitor
  • Research Grade Tocilizumab
  • Tocilizumab - 20 mg/ml in PBS
  • Tocilizumab 20mg/ml
  • 2180
  • 375823-41-9
  • API
Copyright 2019 ? ChemicalBook. All rights reserved
修文县| 墨竹工卡县| 抚远县| 南康市| 洱源县| 汤阴县| 阿拉善右旗| 镇远县| 宁城县| 全椒县| 翼城县| 奎屯市| 阳朔县| 望城县| 涿鹿县| 元朗区| 渝中区| 新津县| 墨玉县| 遂宁市| 贵州省| 尉犁县| 洪江市| 古浪县| 太仆寺旗| 深水埗区| 磴口县| 呈贡县| 四子王旗| 长汀县| 上蔡县| 藁城市| 大新县| 荔浦县| 正镶白旗| 广平县| 修文县| 龙泉市| 长兴县| 福建省| 额尔古纳市|